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Abstract  Article Information 
 
The main purpose of the present research work was to mask the bitter taste of 
the active drug and to formulate the MD tablets by sublimation method. 
Metoclopramide HCl tablets  were prepared by masking the bitter taste with the 
help of Eudragit E-100, then preparing the tablets by using subliming agents i.e. 
camphor and ammonium bicarbonate. The formulations were evaluated for 
weight variation, hardness, friability, drug content, wetting time, In vitro 
disintegration time and In vivo dispersion, mouth feel and in vitro dissolution 
studies. All the formulations comply with the test for weight variation as per 
Indian Pharmacopeia (IP) and found to be within the limits. The drug content of 
all the formulations was within the acceptable limits. Disintegration time of all 
the formulations was found less than 1 min. Wetting time values were giving 
direct relation to the disintegration time values because by increasing tablet 
porosity, more water can be absorbed. The best formulation showed good 
release profile with maximum drug being released at all time intervals. The 
present research work helped in understanding the effect of formulation 
processing variables especially the subliming agent on the drug release profile 
for MD tablets. The present study demonstrated good potentials in quick 
absorption, improved bioavailability and patient compliance. 
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Oral delivery is currently the gold standard in 
the pharmaceutical industry where it is regarded 
as the safest, most convenient and most 
economical method of drug delivery having the 
highest patient compliance (Bhowmik, 2009). 
Many patients have difficulty swallowing tablets 
and hard gelatin capsules and consequently do 
not take medications as prescribed. It is 
estimated that 50% of the population is affected 
by this problem, which results in a high 
incidence of noncompliance and ineffective 
therapy (Luca, 2001). Elderly patients may find  
 
the administration of the conventional oral 
dosage forms difficult as they regularly require 
medicines to maintain a healthy life (Hanawa, 
1995).  Children may also have difficulty in 
ingesting because of their underdeveloped 
muscular and nervous systems (Porter, 2001). 
Drinking water plays an important role in the 
swallowing of oral dosage forms. Often times 
people experience inconvenience in swallowing 
conventional dosage forms such as tablet when 
water is not available, in the case of the motion 
sickness (kinetosis) and sudden episodes of 
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coughing during the common cold, allergic 
condition and bronchitis (Sagar, et al., 2011).  
Unfortunately, majority of the drugs have a 
natural bitter taste that can create a burning 
feeling in the throat or in the mouth. In 
particular, a bitter taste can decrease the 
patient compliance and thus reducing an 
effective pharmacotherapy. In order to achieve 
an acceptable palatability, the addition of flavors 
or sweeteners is limited and may not be 
efficient enough to mask the taste buds of drugs 
and requires the use of technological processes 
(Pankaj, 2010). Thus a number of taste 
masking technologies like use of ion exchange 
resins, the inclusion complexes with 
cyclodextrins, melt granulation and also 
Eudragit E-100. 
Methods to improve patient’s compliance 
have always attracted scientists towards the 
development of fancy oral drug delivery 
systems. Among them, mouth dissolving drug 
delivery systems (MDDDS) have acquired an 
important position in the market by overcoming 
previously encountered administration problems 
and contributing to extension of patent life 
(Shukla et al., 2009). 
MDDT’s disintegrated and/or dissolve rapidly 
in the saliva without the need for water. Some 
tablets are designed to dissolve in saliva 
remarkably fast, within a few seconds, and are 
true fast-dissolving tablets (Bhupendra and 
Nayan, 2009). 
Metoclopramide hydrochloride has got central 
antidopaminergic effect and is used mainly as 
antiemetic and antinauseant. Chemically, 
metoclopramide is 4-amino-5-chloro-N-[(2 -
diethylamino) ethyl]- 2-methoxy benzamide 
(Budavari, 2001) 
Thus in our present study, the bitter taste of 
the drug (Metoclopramide HCl) was masked by 
forming the granules with the Eudragit E-100, 
and the MD tablets were prepared by 
sublimation method for better patient 
compliance.  
 
MATERIALS AND METHODS 
Materials 
Metoclopramide HCl was obtained from 
Elvina Pharmaceuticals Pvt. Ltd., Dharwad. 
Eudragit E-100 obtained as a gift sample from 
Degussa Pvt. Ltd Mumbai. Ammonium 
bicarbonate and camphor were purchased from 
S.D. Fine Chemicals Ltd., Mumbai. Mannitol 
was purchased from Loba Fine Chemicals, 
Mumbai. Aspartame was gift sample from Micro 
Lab Ltd., Bangalore. Trusil Orange and 
Peppermint DC (IFF) were kindly supplied by 
Indoco Remedies, Goa. All other ingredients 
were used of analytical grade. 
 
Taste Masking of Drug by Eudragit E-100 
Here in our present study, first the bitter drug 
Metoclopramide HCl was properly mixed with 
the suitable different proportion (Drug: polymer 
ratio 1:1, 1:2, 1:3, 1:4) of Eudragit E-100. Then 
the 10% ethanol is added to the mixture of drug 
with Eudragit E-100 in the beaker. Then a gel 
containing the mixture of the drug and Eudragit 
E-100 was prepared; using this prepared gel, 
the taste masked granules were prepared by 
the extrusion method. The prepared gel was 
manually pressed out using a syringe. After 
extrusion of the gel, ethanol was removed by 
evaporation overnight at room temperature and 
subsequently the solidified gel in the shape of a 
string was crushed into granules using the 
mortar and pestle (Tatsuya, 1999). The 
prepared taste masked granules were sieved at 
60 # and used for further studies.  
 
Preparation of MD Tablets 
All the ingredients were sieved through 60# 
sieve. The subliming agents camphor and 
ammonium bicarbonate were used in different 
varying amounts (5%, 10%, 15%, 20%, 25%) 
separately, the taste masked granules (Drug: 
Eudragit E-100 ratio 1:2), Mannitol and Avicel PH 
102 were mixed together. Then aspartame as 
sweetening agent, Trusil Orange and Peppermint 
DC (IFF) as flavouring agent were mixed and 
magnesium stearate with talc as a flow promoter 
was added lastly and mixed properly. The mixture 
was compressed into 200mg tablets using flat 
face round 8mm on rotary tablet machine. Drug 
containing subliming agents were then placed in 
an oven at 60 ºC to eliminate the subliming 
agents by sublimation (Koizumi et.al., 1997). A 
sample of 20 tablets was labeled and weighed 
before and after sublimation of subliming agents 
to determine the weight loss.  Five formulations 
were prepared for each subliming agents, 
camphor as named as MEC and ammonium 
bicarbonate as MEN. 
 
Angle of Repose 
Angle of repose was determined using funnel 
method. The blend was poured through funnel 
that can be raised vertically until a maximum 
cone height (h) was obtained. Radius of the 




heap (r) was measured and angle of repose 




Where, θ is the angle of repose, h is height of 
pile; r is radius of the base of pile. 
 
Bulk Density 
Apparent bulk density was determined by 
pouring presieved drug excipient blend into a 
graduated cylinder and measuring the volume 
and weight “as it is”. It is expressed in g/ml and 
is given by  





It was determined by placing a graduated 
cylinder, containing a known mass of drug- 
excipient blend, on mechanical tapping 
apparatus. The tapped volume was measured 
by tapping the powder to constant volume. It is 






Powder Flow Properties  
The flow properties were determined by 
Carr’s Index (I) and it is expressed in 





                                                     
 
Post - Compression Parameters 
Uniformity of thickness, hardness, friability 
test, weight variation test and drug content 
uniformity were performed for all the prepared 
formulations according IP (1996) specifications. 
The other different evaluation parameters 
procedure were briefly explained below 
  
Wetting Time 
The method was applied to measure tablet 
wetting time. A piece of tissue paper folded 
twice was placed in a small petridish (i.d. = 6.5 
cm) containing 6 ml of water, a tablet was put 
on the paper, and the time for complete wetting 
was measured. Three trials for each batch were 
performed and standard deviation was also 
determined (Yunxia et al., 1996). 
 
In vitro Dispersion Time 
In vitro dispersion time was measured by 
dropping a tablet in a measuring cylinder 
containing 10 ml of pH 6.8 (simulated saliva 
fluid). Three tablets from each formulation were 
randomly selected and in vitro dispersion time 
was performed.  Standard deviation was also 
determined and in vitro dispersion time is 
expressed in seconds. 
   
In vitro Disintegration Test 
The process of breakdown of a tablet into 
smaller particles is called as disintegration.  The 
in vitro disintegration time of a tablet was 
determined using disintegration test apparatus 
as per IP specifications.  
 
Place one tablet in each of the 6 tubes of the 
basket.  Add a disc to each tube and run the 
apparatus using pH 6.8 (simulated saliva fluid) 
maintained at 372 0C as the immersion liquid.  
The assembly should be raised and lowered 
between 30 cycles per minute in the pH 6.8 
maintained at 372 0C. The time in seconds 
taken for complete disintegration of the tablet 
with no palpable mass remaining in the 
apparatus was measured and recorded.  
 
Mouth feel and Disintegration in the Oral 
Cavity Mouth feel 
To know mouth feel of the tablets, the same 
human volunteers held the disintegrated 
particles in the mouth for 30 seconds and the 
taste sensation felt was recorded. 
 
In Vivo Disintegration Time 
Three healthy human volunteers, whose 
informed consent was first obtained, were 
selected for the study.  Each volunteer 
randomly took one tablet from each formulation 
and kept on the tongue.  The time taken for 
complete disintegration of the tablet on the 
tongue was noted.  It is expressed in seconds.  
After the test, mouth was washed with distilled 
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                                             Mass of Powder  
TBD (Tapped Bulk Density) =                                                               
                                                Tapped Volume of Packing 
                                       Mass of Powder 
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                                      TBD – LBD x 100 
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(n=3)  (mg) 
MEC1 3.30  0.000 0.6535 201.16  1.49 96.20  0.5204 
MEC2 3.37  0.100 0.6991 199.84  1.45 99.25  0.7603 
MEC3 3.43 0.116 0.7711 201.00  1.46 99.79  0.1909 
MEC4 3.40  0.000 0.8132 198.85  1.46 98.65  0.6519 
MEC5 3.60 0.100 0.9054 201.42  1.81 99.00  0.8197 
MEN1 3.50  0.000 0.7489 199.89  1.67 97.13  0.7906 
MEN2 3.43  0.058 0.6109 200.83  1.81 98.50  0.6960 
MEN3 3.57  0.116 0.6766 201.18  1.44 99.38  0.3750 
MEN4 3.53  0.058 0.8278 199.94  1.88 98.55  0.4155 
MEN5 3.57  0.058 0.8836 198..02  1.44 97.38  0.6614 
 
 
In vitro Dissolution Studies   
The release rate of prepared tablet was 
determined using USP dissolution testing 
apparatus II (paddle type). The dissolution test 
was performed using 900 ml of 0.1 N HCl, at 
37±0.5 0C and at 50rpm, suitable sample was 
withdrawn from the dissolution apparatus, and it 
was replaced with fresh dissolution medium. 
Absorbance of these solutions was measured at 
273 nm UV spectrophotometer (USP, 2000). 
 
Stability Studies 
In the present study, stability studies were 
carried out at 25 0C/60% RH and 40 0C/75% RH  
for a specific time period according to the ICH 
guidelines (Natalie, 1997). 
 
RESULTS AND DISCUSSION  
Many patients, especially elderly find it 
difficult in swallowing tablets, capsules, fluids 
and thus do not comply with prescription, which 
results in high incidence of non-compliance 
oriented research has resulted in  bringing out 
many safer and newer drug delivery systems. 
Rapidly disintegrating/dissolving tablet is one of 
such example, for the reason of rapid 
disintegration or even with saliva. Significance 
of this drug delivery system includes 


















MEC1 32.83 0.59 0.70 15.69 
MEC2 32.83 0.55 0.63 12.73 
MEC3 25.56 0.51 0.61 16.95 
MEC4 30.96 0.46 0.56 18.18 
MEC5 29.74 0.53 0.61 14.04 
MEN1 30.57 0.50 0.61 18.00 
MEN2 29.06 0.51 0.59 13.52 
MEN3 28.73 0.55 0.64 14.55 
MEN4 30.38 0.58 0.67 13.46 
MEN5 29.05 0.54 0.64 15.22 




















MEC1 54.000.00 42.000.00 49.330.58 60.000.00 + 
MEC2 46.330.58 38.001.00 40.671.53 53.330.58 + 
MEC3 39.670.58 36.330.58 35.330.58 44.000.00 + 
MEC4 37.330.58 32.330.58 37.330.58 41.001.00 + 
MEC5 35.670.58 34.000.58 33.331.53 38.331.53 + 
MEN1 44.000.00 42.000.00 49.330.58 57.000.00 + 
MEN2 38.330.58 36.001.00 40.671.53 45.330.58 + 
MEN3 30.670.58 29.330.58 34.330.58 38.000.00 + 
MEN4 39.330.58 35.330.58 42.330.58 44.001.00 + 
MEN5 28.670.58 34.330.58 37.331.53 42.331.53 + 
     “+” Good mouth feel 
 
Figure 1. Comparison of wetting, In vitro disintegration, In vitro dispersion and In vivo Disintegration 
time for camphor formulations. 
 
 
dosage, ease of portability, alternative to liquid 
dosage forms, ideal for paediatric and geriatric 
patients and rapid onset of action (Seager, 
1998 and Habib et al., 2000). 
 
Mouth dissolving tablets are also called as 
rapidly dissolving, rapidly disintegrating, 
orodispersible, orally disintegrating, fast 
dissolving, fast disintegrating tablets. These 
tablts shows better patinet compliance, 
improved bioavailablity and dissolution rate, and 
observes maximum stability. 
 
In our present study, the granules were 
formed by masking bitter taste of the drug was 
masked with Eudragit E-100 and then granules 
were mixed with the subliming agents i.e. 
camphor and ammonium bicarbonate 
separately and other ingredients were mixed 
and the tablets were prepared.  
 
Evaluation of Pre-compression Properties 
For all the prepared formulation, blend of drug 
and excipients was prepared and evaluated for 
pre-compression properties shown in Table 1. 
For camphor formulations the Bulk density was 
found between 0.46 to 0.59 gm/cm
3
, tapped 
density between 0.56 to 0.70 gm/cm
3
, % 
compressibility found to be 12.73 to 18.18 and 
angle of repose found to 29.74 to 32.83. For 
ammonium bicarbonate formulations bulk 
density found between 0.50 to 0.58 gm/cm3, 
tapped density between 0.59 to 0.67 gm/cm3, % 
compressibility found to be 13.46 to 18.00 and 
angle of repose found to 29.05 to 30.57. All the 




























Figure 2. Comparison of wetting, In vitro disintegration, In vitro dispersion and In vivo disintegration 
time for Ammonium bicarbonate formulations. 
 
 
Figure 3. Drug release profile of Camphor formulations. 
 
 









































































































properties for direct compression and hence 
tablets were prepared by using direct 
compression.  
 
Evaluation of Post Compression Properties  
The mouth disintegrating tablets were 
prepared by direct compression method. The 
different post compression parameters were 
evaluated. Friability of the tablets was found 
below 1 % indicating a good mechanical 
resistance of tablets. Uniformity of thickness, 
drug content, weight variation results were 
depleted in the Table 2.  Hardness of both 
different subliming agents formulations found 




FTIR study reveals that there was no 
interaction between drug and excipients for all 
the formulations.  
 
Wetting time is closely related to the inner 
structure of the tablet. Due to formation of the 
porous structure in the tablet, the wetting of the 
tablet leads faster as the concentration of the 
subliming agent increases. This experiment 
mimics the action of saliva in contact with the 
tablet to illustrate the water uptake and 
subsequent wetting of tablet. This showed that 
wetting process was very rapid in almost all 
formulations. This may be due to presence of 
maximum number of pores leads to ability of 
wetting and also capacity of water absorption. 
 
In vitro dispersion and in vitro disintegration 
time were carried for all the formulations and 
results were depicted in the Table 3. 
Dispersiblity and disintegration was faster as 
the porous nature of the tablets. High porosity 
was greater as the concentration of the 
subliming agent increases. This porosity nature 
helps in disintegration and dispersion of the 
tablet. In all the formulations, tablets had high 
porosity and consequently lower wetting times. 
In this addition, the wetting time values were 
giving direct relation to the disintegration time 
values because by increasing tablet porosity, 
more water can be absorbed easily, facilitating 
tablet breakdown.  In vivo disintegration study 
also performed by keeping the tablet in the 
human volunteer mouth and results were 
depicted in Table 3. Thus oral disintegration 
values of tablet were higher than those of the in 
vitro values, thus this may be due to smaller 
volume of water in the oral cavity. Comparison 
study also carried out for In vitro dispersion, In 
vitro disintegration, In vivo disintegration and 
wetting time and shown in figure 1 and 2. 
 
 As the concentration of camphor and 
ammonium bicarbonate increases, there will be 
more number of pores formations in the tablet, 
ultimately water/ saliva can enter and absorb 
more quantity, which will lead to rapid 
disintegration. Another ingredient which is 
included in the formulations is avicel PH102, 
which is also responsible for disintegration of 
tablet.  
 
The healthy human volunteers participated in 
taste evaluation test, were asked to give their 
opinion about the feeling of smoothness or 
grittiness of the dispersion soon after the tablet 
got disintegrated. All the formulations show 
smooth and pleasant mouth feeling, thus fulfill 
the requirements of MD tablets. 
 
In vitro release studies were carried out using 
USP tablet dissolution test apparatus paddle 
method at 37±0.5 °C, taking 900 ml of 0.1N HCl 
as dissolution medium. Speed of rotation of the 
paddle was set at 50 rpm. Aliquots of 1 ml were 
withdrawn at different time interval and replaced 
from fresh dissolution medium and analyzed 
spectrophotometrically at 273 nm. All 
formulations showed more than 90% within 10 
min. The in vitro dissolution profile indicated 
faster and maximum drug release from 
formulation MEN3, MEC3 and MEC4. The 
release profile was shown in Figure 3 and 4 
 
The optimized formulations were selected on 
the basis of hardness, friability, and drug 
content and disintegration time and drug 
release. The selected formulations (MEC3, 
MEC4 and MEN3) were found stable and not 




From the results obtained, it can be concluded 
that the MD tablets can be prepared by 
sublimation method. Eudragit E-100 can be used 
for masking the bitter taste in the ratio of 1:2. 
Physical properties of all prepared tablets 
formulations were acceptable. A high porosity 
was achieved due to formation of many pores 
after removal of sublimable materials. Drug 
release also found maximum within short period.  
The prepared tablet gives benefit in terms of 
patient compliance, rapid onset of action, 
increased bioavailability, low side effect and good 
stability which make these tablets popular as a 
dosage form.  
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